Data as of Dec 06
| +0.23 / +1.00%|
The 5 analysts offering 12-month price forecasts for Sagent Pharmaceuticals Inc have a median target of 25.00, with a high estimate of 26.00 and a low estimate of 21.00. The median estimate represents a +7.34% increase from the last price of 23.29.
The current consensus among 6 polled investment analysts is to Hold stock in Sagent Pharmaceuticals Inc. This rating has held steady since November, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.